Aug 11 8 questions about the experimental Ebola drug headed to Africa By Lauran Neergaard, Associated Press The Liberian government said Monday that it will receive doses of the drug to treat two doctors in the country. They would be the first Africans to receive it. Continue reading
Jun 28 Watch Are generic drugs being delayed to market? By PBS News Hour Are generic drugs being delayed to market by so-called "pay for delay" deals between drug companies? The deals happen after generic drug companies challenge the patents on brand-name drugs. The settlements include a date that the generic drug can enter… Continue watching
Apr 23 Watch New Hepatitis-C drug raises hope at a hefty price By PBS News Hour A new drug has a 90 to 100 percent chance of curing the Hepatitis-C virus, but costs tens of thousands of dollars for a course of treatment. The announcement by the manufacturer that it earned more than $2 billion in… Continue watching
Apr 19 Watch What’s keeping less expensive biologic drugs from the U.S. market? By PBS News Hour Continue watching
Mar 26 25 pharmaceutical companies will phase out animal antibiotics By Mary Clare Jalonick, Associated Press The Food and Drug Administration says 25 pharmaceutical companies are voluntarily phasing out the use of antibiotics for growth promotion in animals processed for meat. Continue reading
Feb 08 Watch Saturday, February 8, 2014 By PBS News Hour On this edition, a rare alliance brings major drug companies together to fight serious diseases like diabetes and rheumatoid arthritis. Later, in our signature segment, a financially strapped city struggles to fulfill its obligations to retired public employees. And, a… Continue watching
Feb 08 Watch Ten big drug companies unite to study major diseases By PBS News Hour Ten big pharmaceutical companies are uniting with the National Institutes of Health in a five-year cooperative program to study major diseases. Continue watching
Sep 23 Democrats Revolt Over $80 Billion Pharmaceutical Deal Senate Finance Committee Chairman Max Baucus faced the first major fight over his health care legislation Tuesday, as fellow Democrats challenged the $80 billion deal that he and the White House struck with drug makers to help pay for health… Continue reading
Jun 22 Pharmaceutical Companies Offer $80 Billion Toward Health Care Reform By Admin, PBS News Hour The U.S. pharmaceutical industry agreed Saturday to spend $80 billion over the next 10 years to reduce drug costs for seniors and help pay for President Barack Obama's proposed health care reform plan. Continue reading